Early Proteomic and Metabolomic Signatures in Diabetes Associated with Progression to Diabetic Retinopathy Over 1–2 Years - Scorecard - MDSpire

Early Proteomic and Metabolomic Signatures in Diabetes Associated with Progression to Diabetic Retinopathy Over 1–2 Years

  • By

  • Zhao, Jing

  • Cao, Yitao

  • Chai, Zhi

  • Xie, Hanghang

  • Gu, Dandan

  • Yanchun, Zhang

  • Dongling, Niu

  • Liu, Hongli

  • Lei, Ting

  • May 29, 2026

  • 0 min

Share

Clinical Scorecard: Initial Proteomic and Metabolomic Indicators in Diabetes Linked to the Development of Diabetic Retinopathy Within 1–2 Years

At a Glance

CategoryDetail
Condition
Key MechanismsRemove or provide source.
Target Population
Care Setting

Key Highlights

    Guideline-Based Recommendations

    Diagnosis

      Management

        Monitoring & Follow-up

          Risks

            Patient & Prescribing Data

            Remove speculative language.

            Clinical Best Practices

              Related Resources & Content

                Original Source(s)

                Early Proteomic and Metabolomic Signatures in Diabetes Associated with Progression to Diabetic Retinopathy Over 1–2 Years

                • by Zhao, Jing , Cao, Yitao , Chai, Zhi , Xie, Hanghang , Gu, Dandan , Yanchun, Zhang , Dongling, Niu , Liu, Hongli , Lei, Ting

                • May 29, 2026

                Related Content

                AACE 2026: Will AI replace endocrinologists?

                The same technology drawing patients away from clinic may also improve the patient-physician relationship.

                Detection of Referable Diabetic Retinopathy using Machine Learning on Routine Clinical Data

                Screening for Diabetic Retinopathy in a Rural High-Latitude Community in Northern Norway